Vazquez L, Encinas M, Morin L, Vilches P, Gutierrez N, Garcia-Sanz R, Caballero D, Hurle A. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Haematologica [Internet]. 1999Mar.1 [cited 2026Nov.14];84(3):231-6. Available from: https://haematologica.org/article/view/1321